Rambus reported record annual revenue and earnings for fiscal 2025, fueled by strong DDR5 adoption and AI-driven data center growth. While a one-time supply chain issue is expected to pressure Q1 2026 product revenue, management expressed confidence in a swift recovery and sustained long-term momentum.
Palantir Technologies' fourth-quarter earnings reveal a seismic shift, with U.S. commercial revenue for its AI Platform soaring 137%. The data analytics firm posted its highest growth rate as a public company, powered by massive government contracts and enterprise adoption, while setting aggressive targets for the year ahead.
As Palantir Technologies reports a massive surge in U.S. government revenue, CEO Alex Karp publicly defends the company's controversial surveillance platforms, insisting they contain safeguards against overreach. The defense comes amidst growing public and political scrutiny over its contracts with immigration enforcement agencies.
Palantir Technologies' stock surged after hours as its Q4 earnings and bullish 2026 guidance surpassed analyst forecasts, signaling a powerful acceleration in its AI software business and vindicating CEO Alex Karp's long-term strategy.
The data analytics firm's fourth-quarter results showcase a decisive shift, with U.S. commercial revenue soaring 137% and profitability silencing long-time skeptics, even as its premium valuation demands sustained execution.
Teradyne (TER) shares surged over 10% after the semiconductor test equipment leader posted Q4 revenue and profit that smashed analyst estimates, fueled by surging demand from AI chipmakers. The company's bullish guidance signals confidence in a sustained industry upcycle.
As Amazon prepares to release its Q4 earnings, analysts are eyeing accelerated AWS growth and robust advertising revenue as key drivers that could propel the stock higher, mirroring its October surge.
DaVita Inc. shares soared after the kidney care provider posted robust fourth-quarter results and issued a 2026 profit forecast that significantly exceeded Wall Street expectations, signaling resilience against cost pressures and past operational challenges.
While many AI stocks trade at sky-high premiums, Nebius Group presents a contrasting case. Analysts project a staggering revenue surge for 2026, suggesting its current valuation might not fully reflect its growth trajectory in the competitive cloud AI space.
SoFi Technologies dazzles with its first $1 billion revenue quarter and a push into crypto payments, but a stark valuation gap has emerged, raising questions about whether its stock price has already outpaced its growth narrative.
The U.S. Treasury Department has outlined its borrowing needs for the first half of 2026, projecting $574 billion in net marketable debt for Q1 followed by a significantly lower $109 billion for Q2, amid adjustments to cash flow forecasts and federal cash balances.
Amid surging government revenue and public protests over its ICE contracts, Palantir CEO Alex Karp defends the company's controversial surveillance technology, framing it as a safeguard against state overreach rather than an enabler.
An AI-driven analysis suggests Cloudflare (NET) shares may face headwinds over the next two months, projecting an average price near $168. The forecast contrasts with bullish long-term analyst views, highlighting the tension between immediate technical signals and the company's strategic positioning in edge security and AI infrastructure.
While Nufarm's share price has seen a modest 10% recovery in recent months, investors who bought three years ago are still sitting on heavy losses, with the stock down 60% over that period. The agricultural chemical company's declining revenue and lack of profitability continue to weigh on market sentiment.
As investors navigate a complex economic landscape, companies with significant insider ownership and robust earnings forecasts are drawing attention. We examine three ASX-listed firms where leadership's skin in the game aligns with ambitious growth projections.
Despite solid revenue growth, Microvast Holdings (NASDAQ: MVST) has seen its share price collapse over the past five years, erasing billions in market value and testing the patience of long-term investors.
The Swiss watchmaker reported a dip in 2025 profits amid currency headwinds and strategic investments, but forecasts a return to broad-based growth next year, buoyed by robust second-half sales and strong performance in key markets like the Americas.
Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.
IDEXX Laboratories (IDXX) reported robust double-digit growth for Q4 2025, driven by record placements of its premium diagnostic instruments and expanding test utilization. While acknowledging persistent softness in U.S. veterinary visit volumes, the company outlined a confident initial 2026 forecast, banking on its innovation pipeline and the transformative impact of its inVue Dx system.
Micron Technology shares surged again Monday, fueled by a new analyst report highlighting strong demand for its high-bandwidth memory chips and forecasting a significant rise in DRAM prices through 2026.
